Trial completion shift to 2023 is unfortunate.
On the positive, company is actively working with different markets and provided tangible updates for Japan, Canada, US, India and China. Data from Monash trial so far appears to exceed clinical expectations.
- Forums
- ASX - By Stock
- Ann: FELIX System commercialisation, regulatory plan and trial
Trial completion shift to 2023 is unfortunate. On the positive,...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MEM (ASX) to my watchlist
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.06M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 335850 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 3584999 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 335850 | 0.007 |
18 | 13853665 | 0.006 |
6 | 2049000 | 0.005 |
2 | 1933333 | 0.004 |
3 | 1300000 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 3584999 | 6 |
0.010 | 1145842 | 2 |
0.011 | 286112 | 2 |
0.012 | 750000 | 2 |
0.013 | 500000 | 1 |
Last trade - 16.12pm 18/07/2024 (20 minute delay) ? |
Featured News
MEM (ASX) Chart |
Day chart unavailable